NR 293 Week 6 Assignment_RUA_Kisunla Medication Overview

NurSing Management Patient Education (Special ConSiderationS) Monitoring for adverSe KiSunla iS indicated for thoSe who are This drug can cause the effectS development of ARIA and infusion experiencing SymptomS of early related reactions which can result in Monitoring for infuSion Alzheimer’S diSeaSe. these adverse effects related reactionS Patient’S Should NOT miSS a doSe of AdverSe EffectS Giving preScribed doSe their KiSunla. If a doSe iS miSSed, Headache Difficulty walking properly patientS are encouraged to receive the ConfuSion ChillS miSSing doSe aS Soon aS poSSible. DizzineSS Irritation of Skin Patient education ViSion changeS ARIA iS a potential Side effect of thiS Sweating drug. PatientS Should continue Seeing NauSea CheSt painS Patient ASSeSSment their primary healthcare provider for Vomiting Trouble breathing routine teStS and ScreeningS, aS thiS SeizureS Take vital SignS drug iS known to cauSe brain Swelling/bleeding Toxicity/ Fatal EffectS Check Pet Scan reSultS PatientS Should monitor for the other Brain Swelling Check genotype reSultS adverSe effectS of thiS drug. Check brain MRI reSultS Do NOT take if pregnant or planning to SpotS of bleeding get pregnant, thiS drug haS no evidence on the Surface of the brain D o w n behind the affect it haS on the b a b y